Loading insider details...
Latest Form 4 (Jun 4, 2026): Grant/Award of 35,000 TRVI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 35,000 | n/a |
| Feb 26, 2026 | Vericel Corp (VCEL) | Exercise/Conversion | 18,250 | n/a |
| Feb 20, 2026 | Vericel Corp (VCEL) | Exercise/Conversion | 18,250 | n/a |
| Jun 13, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 45,000 | n/a |
| May 16, 2025 | Vericel Corp (VCEL) | Exercise/Conversion | 14,062 | $37.3K |
| Apr 11, 2025 | Vericel Corp (VCEL) | Exercise/Conversion | 24,850 | $68.3K |
| Mar 14, 2025 | Vericel Corp (VCEL) | Exercise/Conversion | 26,591 | $51.9K |
| Feb 26, 2025 | Vericel Corp (VCEL) | Exercise/Conversion | 18,250 | n/a |
| Feb 24, 2025 | Vericel Corp (VCEL) | Grant/Award | 182,500 | n/a |
| Feb 20, 2025 | Vericel Corp (VCEL) | Exercise/Conversion | 18,250 | n/a |